Neuronetics, Inc. (STIM) Stock Forecast
STIM analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 4 analysts
- Price target
- $5.75 average of analyst targets
- Upside to target
- +205.0% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $-0.08
- 52-week range
- $1.18 – $3.30
STIM analyst ratings
4 analystsNumber of analysts at each rating.
STIM price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
STIM earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.11 | −$0.11 | −$0.11 | −$0.13 | +15.4% | 1 |
| Current fiscal year (2026) | −$0.47 | −$0.47 | −$0.47 | −$0.59 | +20.3% | 1 |
| Next fiscal year (2027) | −$0.34 | −$0.34 | −$0.34 | −$0.47 | +27.7% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
STIM revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $40.4M | $39.7M | $41.0M | +8.4% | 4 |
| Current fiscal year (2026) | $162.0M | $161.3M | $162.8M | +8.6% | 4 |
| Next fiscal year (2027) | $177.0M | $174.9M | $179.0M | +9.2% | 4 |
STIM EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
STIM revenue: reported and forecast
STIM EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.11 | −$0.11 | −$0.11 | −$0.11 | −$0.11 | −2.9% | 2 up · 0 down |
| Current fiscal year (2026) | −$0.46 | −$0.46 | −$0.47 | −$0.47 | −$0.47 | +1.4% | 1 up · 0 down |
| Next fiscal year (2027) | −$0.34 | −$0.34 | −$0.34 | −$0.34 | −$0.34 | +1.0% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
STIM earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; STIM beat in 5 of 12.
What analysts expect from STIM
4 analysts cover Neuronetics; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.75, 205.0% above the latest close of $1.89. Analysts expect earnings of −$0.47 per share for 2026, +20.3% from a year earlier. For 2027 the average estimate is −$0.34 per share on revenue of $177.0 million. Neuronetics beat the EPS estimate in 5 of the last 12 quarters.
Related: STIM income statement, STIM key metrics, STIM chart. See the STIM stock overview for the latest quote and news.
STIM forecast FAQ
What is Neuronetics's price target?
The average analyst price target for Neuronetics is $5.75, 205.0% above the latest close of $1.89.
Is Neuronetics a buy, hold or sell?
Of 4 analysts covering Neuronetics, 3 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Neuronetics's EPS forecast?
Analysts forecast −$0.47 per share for 2026 (range −$0.47 to −$0.47); for 2027 the estimate is −$0.34.
What is Neuronetics's revenue forecast?
The average revenue estimate for 2026 is $162.0 million, growth of 8.6%; for 2027 it is $177.0 million.
When does Neuronetics report earnings?
Neuronetics is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $-0.08.
Does Neuronetics usually beat earnings estimates?
Neuronetics reported EPS at or above the analyst estimate in 5 of the last 12 quarters.